I tend to agree with you on most of OTC stocks love to have this kind of revenue ONCI has. As long as ONCI shows growth revenue on quarterly basis I don't think shorts can hold this for much longer. At the end revenue speaks for itself. More contracts and more revenue.

However, SB needs to be careful not to shake hand with devil (LAM or other criminal blood sucker capital companies) because it will put too much pressure on PPS